Lipotoxicity as a trigger factor of renal disease
- PMID: 26956132
- DOI: 10.1007/s40620-016-0278-5
Lipotoxicity as a trigger factor of renal disease
Abstract
In the last few decades, rapid changes in lifestyle have led to an alarming increase in the prevalence of obesity and obesity-associated complications. Obese patients are at increased risk of developing hypertension, heart disease, insulin resistance, dyslipidemia, type 2 diabetes and kidney disease. The surplus of calories is normally stored as triglycerides in adipose tissue. However, excess lipids can also accumulate ectopically in other organs, including the kidney, contributing to their damage through toxic processes named lipotoxicity. The kidney is negatively affected by dyslipidemia, lipid accumulation and changes in circulating adipokines that bring about alterations in renal lipid metabolism and promote insulin resistance, generation of reactive oxygen species and endoplasmic reticulum stress, ultimately leading to alterations in the glomerular filtration barrier and renal failure. This review focuses on the pathogenic molecular mechanisms associated with renal lipotoxicity, and presents new insights about potential new therapeutic _targets and biomarkers such as microRNAs and long non-coding RNAs, of relevance for the early detection of lipid-associated kidney disease.
Keywords: Biomarkers; Kidney disease; Lipotoxicity; Long non-coding RNAs; miRNAs.
Similar articles
-
Renal Lipotoxicity-Associated Inflammation and Insulin Resistance Affects Actin Cytoskeleton Organization in Podocytes.PLoS One. 2015 Nov 6;10(11):e0142291. doi: 10.1371/journal.pone.0142291. eCollection 2015. PLoS One. 2015. PMID: 26545114 Free PMC article.
-
Adipose tissue dysfunction in obesity.Exp Clin Endocrinol Diabetes. 2009 Jun;117(6):241-50. doi: 10.1055/s-0029-1192044. Epub 2009 Apr 8. Exp Clin Endocrinol Diabetes. 2009. PMID: 19358089 Review.
-
Insulin Resistance, Obesity and Lipotoxicity.Adv Exp Med Biol. 2017;960:277-304. doi: 10.1007/978-3-319-48382-5_12. Adv Exp Med Biol. 2017. PMID: 28585204 Review.
-
New insights into adipose tissue dysfunction in insulin resistance.Clin Chem Lab Med. 2011 Sep 6;49(12):1925-35. doi: 10.1515/CCLM.2011.697. Clin Chem Lab Med. 2011. PMID: 21892913 Review.
-
Renal lipotoxicity: Insights from experimental models.Clin Exp Pharmacol Physiol. 2021 Dec;48(12):1579-1588. doi: 10.1111/1440-1681.13556. Epub 2021 Sep 23. Clin Exp Pharmacol Physiol. 2021. PMID: 34314523 Review.
Cited by
-
MicroRNAs as Epigenetic Regulators of Obesity.Adv Exp Med Biol. 2024;1460:595-627. doi: 10.1007/978-3-031-63657-8_20. Adv Exp Med Biol. 2024. PMID: 39287866 Review.
-
HDL in CKD-The Devil Is in the Detail.J Am Soc Nephrol. 2018 May;29(5):1356-1371. doi: 10.1681/ASN.2017070798. Epub 2018 Feb 22. J Am Soc Nephrol. 2018. PMID: 29472417 Free PMC article. Review.
-
The expression of apoptosis related genes in HK-2 cells overexpressing PPM1K was determined by RNA-seq analysis.Front Genet. 2022 Nov 1;13:1004610. doi: 10.3389/fgene.2022.1004610. eCollection 2022. Front Genet. 2022. PMID: 36386814 Free PMC article.
-
Dyslipidemia in Kidney Disorders: Perspectives on Mitochondria Homeostasis and Therapeutic Opportunities.Front Physiol. 2020 Sep 3;11:1050. doi: 10.3389/fphys.2020.01050. eCollection 2020. Front Physiol. 2020. PMID: 33013450 Free PMC article. Review.
-
Association between the lipid accumulation product and chronic kidney disease among adults in the United States.Sci Rep. 2024 Sep 13;14(1):21423. doi: 10.1038/s41598-024-71894-2. Sci Rep. 2024. PMID: 39271739 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical